Top 5 Medical Apps on Android in the US for Q1 2024

During the first quarter of 2024, the top 5 medical apps on Android in the United States showcased varied performance metrics in terms of weekly downloads, revenue, and active users. Here’s a closer look at their trends:

epocrates from Epocrates, Inc. saw a steady weekly revenue, peaking at approximately $24K in the final week of February. Weekly downloads started strong at around 1.2K in early January but saw a gradual decline to about 772 by the end of March. Active users also followed a declining trend, starting at 4.4K and ending the quarter at about 3.6K.

Sanford Guide by Antimicrobial Therapy, Inc. had fluctuating weekly revenue, with a peak of $9.2K in mid-January and a low of $4.7K in late February. Downloads were minimal, starting with 15 in the first week and reaching a peak of 145 in mid-February. Active users remained relatively stable, hovering around 400 throughout the quarter.

Davis's Drug Guide from Unbound Medicine, Inc. experienced a significant increase in weekly revenue, reaching $7.9K in mid-February. Downloads were consistent, averaging around 300 per week, with a slight decline towards the end of the quarter.

EndeavorOTC®: Outplay ADHD by Akili Interactive Labs, Inc. showed varied weekly revenue, peaking at $6.6K in early March. Weekly downloads were highest in late January at 1K but declined to around 530 by the end of March.

Migraine Buddy: Track Headache from AptarDH had a steady performance in weekly revenue, with a notable peak of $8K in the last week of March. Downloads remained fairly consistent, averaging around 670 per week. Active users were stable, starting at 17.6K and ending the quarter at approximately 16.3K.

These insights are based on data from Sensor Tower, which provides more detailed analytics and trends for these applications.